Haematological Malignancies Completed Phase 1 Trials for MKC-1 (DB05608)

Also known as: Hematological Malignancies / Hematological Malignancy / Haematological Malignancy / Hematologic malignancy / Hematologic Neoplasms

IndicationStatusPhase
DBCOND0046524 (Haematological Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00506402A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic MalignanciesTreatment